** Aquabounty AQB.O plunges 21% to $2.40 after the bell as
biotech looks to raise equity for second time in less than a
month
** Co announces proposed offering for working capital costs
related to growing its first batches of fish at Indiana and
Rollo Bay farm sites, and other general corp purposes; does not
disclose size urn:newsml:reuters.com:*:nGNX2vbjJ3
** H.C. Wainwright acting as sole book-running manager
** Co last raised equity on Mar 19 by selling 3.35 mln
shares at $2.25 for gross raise of $7.5 mln urn:newsml:reuters.com:*:nL3N2162DN
** On Mar 8, AQB shares more than doubled to close at $4.89
after the FDA allowed import of co's genetically engineered
salmon into the U.S. urn:newsml:reuters.com:*:nL3N20V3SW
** Co has 18.7 mln shares outstanding as of Mar 18, per
Refinitiv data
** AQB shares gained 7% to close at $3.04 on Thurs,
extending YTD gain to 48%
** AquaBounty is majority-owned unit of Intrexon Corp
XON.O
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))